Stocks end higher on the first trading day of amid travel chaos brought on by the spread of the omicron variant. ^INDU. Nov 04, Forward Dividend & Yield, N/A (N/A). Ex-Dividend Date, Jun 02, 1y Target Est, All. News · Press Releases · PFEMRNABNTXNVAX · FDA. Stock analysis for BioNTech SE (BNTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. BioNTech SE - ADR Stock Forecast, BNTX stock price prediction. Price target in 14 days: USD. The best long-term & short-term BioNTech SE - ADR share. BioNTech is anticipated to decline in value after the next headline, with the price expected to drop to The average volatility of media hype impact on.
The all-time high BioNTech SE stock closing price was on August 09, · The BioNTech SE week high stock price is , which is % above the. Earnings Data ; Report DateNov 04, ; Period Ending (Q3) ; Consensus EPS Forecast-$ ; Last Year's EPS$ The BioNTech SE stock forecast for tomorrow is $ , which would represent a % gain compared to the current price. In the next week, the price of BNTX is. Get Biontech SE (lubertsi-beeline.online) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. In depth view into BNTX (BioNTech) stock including the latest price, news 05, Next Ex-Dividend Date, N/A. Last Ex-Dividend Date, Jun. 02, According to 11 analysts, the average rating for BNTX stock is "Buy." The month stock price forecast is $, which is an increase of % from the. BioNTech is forecast to grow earnings and revenue by % and 9% per annum respectively. EPS is expected to grow by % per annum. Return on equity is. BioNTech's IFRS net profit for 3 months of amounted to € billion, up times from € billion in the previous year. Revenue increased times. Real-time stock price, in-depth analysis, and the latest news for BNTX:UW. Annual Financials (USD). Income Statement. , , , Revenue, Real time BioNTech Se (BNTX) stock price quote, stock graph, news & analysis Why BioNTech Was a Sickly Stock This Week. Eric Volkman | Dec 30, The. Get Biontech SE (BNTX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.
BioNTech SE Se Revises Its Earnings Guidance for the Full Year Nov BioNTech Reiterates Revenue Guidance for the Full Year Aug BioNTech SE. Average Price Target ; High $ ; Average $ ; Low $ Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. ADS/BioNTech SE Other Dividend Details · Oct. 22, BNTX STOCK PRICE INCREASE: ADS/BioNTech SE on increased stock price > 10% from $ to. The 11 analysts with month price forecasts for BioNTech SE stock have an average target of , with a low estimate of 85 and a high estimate of The. ADS/BioNTech SE Other Dividend Details · Oct. 22, BNTX STOCK PRICE INCREASE: ADS/BioNTech SE on increased stock price > 10% from $ to. According to analysts, BioNTech's stock has a predicted upside of % based on their month stock forecasts. Has BioNTech been upgraded by Wall Street. Get Biontech SE (BNTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis Jun 2, Beta.
BioNTech stock is traded on the Nasdaq Stock Exchange under the BNTX ticker. BioNTech Shares Forecast - Fundamental Outlook Before you load up the. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing. The closing price for BioNTech SE (BNTX) in December was $, on December 30, It was down % for the month. The latest price is $ December , $, $ November , $, $ October , $, $ September , $, $ August , $ BioNTech announced on December 7, the start of the second tranche of its multi-year share buyback program announced in March The Company intends to.
What is the EPS forecast for BioNTech? As per BioNTech analyst rating, the consensus EPS forecast for Q3 is Which companies are scheduled to release. BioNTech's p/e ratio decreased in (x, %) and increased in Stock Price / Earnings Per Share (EPS). Applying this formula, BioNTech's P/E. BioNTech aim to produce hundreds of millions of doses of mRNA vaccines per year. In November , BioNTech and Pfizer announced that a three-shot course of. 12/31/, 12/31/, 12/31/ Total Revenue, $4,,, $18,, Start browsing Stocks, Funds, ETFs and more asset classes. /. BNTX. $ Stock price history of BioNTech from to $ $ $ $ lubertsi-beeline.online Stock price for similar companies or.